Search clinical trials for: FK228 (romidepsin)
Total 107 results
-
CelgeneCompletedCarcinoma, Renal Cell | Prostatic NeoplasmsUnited States, United Kingdom
-
CelgeneCompletedCarcinoma, Renal Cell | Neoplasm MetastasisUnited States
-
National Cancer Institute (NCI)CompletedGastrointestinal Stromal Tumor | Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Adult Rhabdomyosarcoma | Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal... and other conditions
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Chronic Myelogenous Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Relapsing Chronic Myelogenous Leukemia and other conditionsUnited States
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
National Cancer Institute (NCI)CompletedStage IV Squamous Cell Carcinoma of the Hypopharynx | Stage IV Squamous Cell Carcinoma of the Larynx | Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage IV Squamous Cell Carcinoma of the OropharynxUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedGastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Regional Gastrointestinal Carcinoid Tumor | Pulmonary Carcinoid TumorUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Northwestern UniversityAmgenTerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary Syndrome | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IA Mycosis Fungoides/Sezary Syndrome | Stage... and other conditionsUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedGraft Versus Host DiseaseUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Gastric Cancer | Adenocarcinoma of the Stomach | Adenocarcinoma of the Esophagus | Recurrent Esophageal CancerUnited States
-
National Cancer Institute (NCI)Completed
-
CelgeneCompletedPeripheral T-cell LymphomaUnited States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
CelgeneTerminated
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
NYU Langone HealthLudwig Institute for Cancer ResearchTerminatedCutaneous T-cell LymphomaUnited States
-
CelgeneCompletedPancreatic CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); CelgeneActive, not recruitingPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous... and other conditionsUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedLymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
National Cancer Institute (NCI)TerminatedNeoplasms | Mycosis Fungoides | Cutaneous T-Cell LymphomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnOvarian CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
ANRS, Emerging Infectious DiseasesINSERM SC10-US19RecruitingHIV-1-infection, Subtype bBelgium, France
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
The Lymphoma Academic Research OrganisationCompletedEfficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell LymphomaPeripheral T-cell LymphomaSpain, France, Korea, Republic of, Italy, Germany, Singapore, Belgium, Portugal
-
The Lymphoma Academic Research OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of Texas Southwestern Medical CenterGenentech, Inc.; CelgeneCompletedLung Cancer | Metastatic CancerUnited States
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Anne Beaven, MDBoehringer Ingelheim; National Comprehensive Cancer NetworkWithdrawn
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedSolid Tumors | Virally Mediated Cancers and LiposarcomaUnited States
-
Royal Marsden NHS Foundation TrustUnknown
-
CelgeneCompleted
-
National Cancer Institute (NCI)CompletedCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States, Australia
-
Samsung Medical CenterCelgene CorporationCompletedHistologically Proven Extranodal NKTcell LymphomaKorea, Republic of
-
Fondazione Italiana Linfomi ONLUSCompletedPeripheral T-cell LymphomaItaly